qwertyuiopasdfghjklzxcvbnmqwerty uiopasdfghjklzxcvbnmqwertyuiopasd fghjklzxcvbnmqwertyuiopasdfghjklzx cvbnmqwertyuiopasdfghjklzxcvbnmq wertyuiopasdfghjklzxcvbnmqwertyui opasdfghjklzxcvbnmqwertyuiopasdfg hjklzxcvbnmqwertyuiopasdfghjklzxc vbnmqwertyuiopasdfghjklzxcvbnmq wertyuiopasdfghjklzxcvbnmqwertyui opasdfghjklzxcvbnmqwertyuiopasdfg NIFTY OUTLOOK hjklzxcvbnmqwertyuiopasdfghjklzxc REPORT vbnmqwertyuiopasdfghjklzxcvbnmq 18 Sep 2017 wertyuiopasdfghjklzxcvbnmqwertyui opasdfghjklzxcvbnmqwertyuiopasdfg hjklzxcvbnmrtyuiopasdfghjklzxcvbn mqwertyuiopasdfghjklzxcvbnmqwert yuiopasdfghjklzxcvbnmqwertyuiopas th
18th Sep 2017
NIFTY
NIFTY FUT : PIVOT : 10099
R1:10135 S1:10067
R2:10167 S2:10029
R3:10190 S3:10000
NIFTY DAILY CHART NIFTY OUTLOOK Nifty is likely to open with a gap up opening. Momentum indicators are indicating towards a bulls rule ahead in this week. Global market is indicating towards a bullish rally for the Indian market too. Positional traders are advice to average their longs on every -50 pts dips on nifty while for shorts it is strictly advised to use stop loss at 10175.Intraday traders are advised to adopt buy on dips strategy for today. Strategy: Long Nifty fut around 10150 t1 10200 sl 10110 Name FTSE 100 (Sep 15)
Current Value
Change
% Chg
Open
7,295.39
Low
7,215.47
-79.92
-1.11
CAC 40 (Sep 15)
5,213.91
-11.29
-0.22
5,220.89
5,237.17
5,201.97
DAX (Sep 15) Nikkei 225 (Sep 15) Straits Times (Sep 18) Hang Seng (Sep 18) Taiwan Weighted (Sep 18) SGX Nifty (Sep 18)
12,518.81
-21.64
-0.17
12,525.36
12,561.35
12,506.94
19,909.50
102.06
0.51
19,793.80
19,933.40
19,787.65
3,244.22
34.66
1.07
3,230.38
3,246.49
3,225.48
28,108.50
300.91
1.07
27,971.37
28,113.96
27,917.18
10,627.29
46.88
0.44
10,590.80
10,634.53
10,581.81
10,152.00
58
0.57
10,099.00
10,153.50
10,087.50
WWW.EQUITYRESEARCHLAB.COM
7,295.39
High
7,196.58
18th Sep 2017
CORPORATE NEWS -Listings today - Bharat Road Network, Dixon Technologies -Tata Motors' compact SUV offering Nexon will be launched on September 21 -Dr Reddy's Labs intimated exchanges about audit of API Mirfield plant, United Kingdom, by the US FDA -Mahanagar Gas starts piped natural gas (PNG) supply in Dombivaili (East) area of Maharashtra -Laurus Labs receives the EIR from USFDA, and also successfully completes the German Regulatory Authority for Unit 2 and WHO inspections for Units 1 & 3 -Balrampur Chini starts NBFC to invest in financing activities in the education sector -Govt told steel firms to keep process below Rs 40,000 per tonne: BS -Government may raise Rs 15,000 crore from IPO of New India Insurance and GIC Re: BS -Fosun Group to buy 74 percent stake in Gland Pharma for USD 1.1 billion: Mint -Hardcastle, Jubilant, Speciality, Moon Beverages, Lite Bite keen to partner McDonald's: ET -Stakeholders Empowerment Services (SES) urges Bharti shareholders to reject Telenor deal: ET -HDFC Life IPO may be pushed to Q3: ToI -ITC looking to expand by 40 new hotels with 5000 rooms in pipeline: Mint -TVS eyes electric two wheeler space, to roll out products soon: ET -Institutional investors in PTC India seek board representation: ET -Tata Sons seeks shareholders' nod to amend voting rights: ET -Cognizant draws plan to strike 5-10 deals per year -Government to sell Air India Properties owned by them: ET -BPCL eyes government stake in GAIL India for Rs18,000-20,000 crore: Mint -Cadila: Zydus' Nesher Pharma gets US FDA final nod for Oseltamivir powder-Axis Bank keeps its MCLR unchanged
WWW.EQUITYRESEARCHLAB.COM
18th Sep 2017
ERL RESEARCH TEAM Member Name
Designation
Mr. Tuhinanshu Jain Mr. Manish Bimal Mr. Anand Sharma Mr. Sumit Sahu
Research Head Sr. Research Analyst Research Analyst Research Analyst
DISCLAIMER The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Investment in Stocks has its own risks. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. We, however, do not vouch for the accuracy or the completeness thereof. This material is for personal information and we are not responsible for any loss incurred based upon it & takes no responsibility whatsoever for any financial profit s or loss which may arise from the recommendations above. The stock price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Equity Research Lab does not purport to be an invitation or an offer to buy or sell any financial instrument. Analyst or any person related to Equity Research Lab might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Any surfing and reading of the information is the acceptance of this disclaimer. Our Clients (Paid or Unpaid), any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken. Any surfing and reading of the information is the acceptance of this disclaimer. ALL RIGHTS RESERVED.
WWW.EQUITYRESEARCHLAB.COM